Solventum (NYSE:SOLV – Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect Solventum to post earnings of $1.67 per share for the quarter.
Solventum Stock Up 0.1 %
Shares of NYSE:SOLV opened at $64.69 on Tuesday. Solventum has a twelve month low of $60.72 and a twelve month high of $96.05.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on SOLV. Wells Fargo & Company started coverage on shares of Solventum in a research note on Monday, April 8th. They issued an “equal weight” rating and a $69.00 target price for the company. Morgan Stanley started coverage on Solventum in a report on Wednesday, April 10th. They set an “equal weight” rating and a $70.00 price objective on the stock. Finally, Edward Jones began coverage on Solventum in a research report on Tuesday, April 2nd. They set a “hold” rating for the company.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Further Reading
- Five stocks we like better than Solventum
- P/E Ratio Calculation: How to Assess Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Investing In Automotive Stocks
- 3 Value Stocks You Can Buy Before They Become Big
- What Are Growth Stocks and Investing in Them
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.
